Hikaru Murooka • Natsumi Yamamoto • Shiho Amano •, et. al. DOI: 10.7759/cureus.87395 Abstract We report a case of idiopathic retroperitoneal hematoma in an 82-year-old man with moderate COVID-19 pneumonia receiving prophylactic anticoagulation therapy. The patient…[...]
Read More
Abdel-Hameed W. Al-Mistarehi • Shadi El-Akawi • Khalid A. Kheirallah, et. al.DOI: 10.7759/cureus.67467 Abstract Background: Several medications have been proposed to manage COVID-19, with controversial data regarding their clinical benefits. We aimed to investigate the clinical…[...]
Read More
by J.M. Phelps Gateway Pundit Using data from the Department of Defense (DOD) Joint Trauma System (JTS), The Remdesivir Papers came to life on October 4, 2024. In the 5,400-word report by J.M. Phelps…[...]
Read More
SARS-CoV-2 keeps changing. What does this mean for the treatment of COVID-19? By EKATERINA PESHEVA January 3, 2023 Research Harvard As the world enters year four of the COVID-19 pandemic, scientists have…[...]
Read More
Rajesh T. Gandhi, MD1; Preeti N. Malani, MD, MSJ2,3; Carlos del Rio, MD4, JAMA. 2022;327(7):617-618. doi:10.1001/jama.2022.0335 Substantial progress has been made in therapeutics for nonhospitalized patients with COVID-19, but supply of and access to treatment remain limited. This Viewpoint…[...]
Read More
Authors: Alicia Powe May 14, 2022 Gateway Pundit After two years of inundating the public with propaganda and fear surrounding COVID-19, the mainstream media and the federal government turned the…[...]
Read More
Authors: By: Neesha C. Siriwardane & Rodney Shackelford, DO, Ph.D. April 15, 2020 Introduction to COVID-19 Coronaviruses are enveloped single-stranded RNA viruses of the Coronaviridae family and order Nidovirales (1). The viruses are named for…[...]
Read More
Contributors BC, CW, and YeW had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the…[...]
Read More
Authors: By Ralph Ellis October 19, 2020 -- A large study sponsored by the World Health Organization found that remdesivir doesn’t help hospitalized patients with COVID-19 survive and doesn’t even…[...]
Read More
Authors: NIAID Office of Communications Hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than similar patients who received placebo, according to a preliminary data analysis…[...]
Read More